Join to View Full Profile
34th & Civic Center BlvdChildren's Hospital Of PhiladelphiaPhiladelphia, PA 19104
Phone+1 215-590-1000
Fax+1 215-590-2204
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nicole Hasbrouck, MD is a pediatric hematologist/oncologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania, Maryland, and District of Columbia.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2005 - 2008
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2002 - 2005
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2002
Certifications & Licensure
DC State Medical License 2011 - 2027
MD State Medical License 2012 - 2013
PA State Medical License 2005 - 2012- PA State Medical License 2005 - 2012
IL State Medical License 2002 - 2005
Publications & Presentations
PubMed
- 11 citationsEarly administration of COVID-19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy.Artur Belov, Yin Huang, Carlos H Villa, Barbee I Whitaker, Richard Forshee
American Journal of Hematology. 2022-06-01 - 32 citationsDevelopment and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma.Hyung Park, Thaddeus Tarpey, Mengling Liu, Keith Goldfeld, Yinxiang Wu
JAMA Network Open. 2022-01-04 - 373 citationsConvalescent Plasma Antibody Levels and the Risk of Death from Covid-19.Michael J. Joyner, Rickey E. Carter, Jonathon W. Senefeld, Stephen A. Klassen, John Mills
The New England Journal of Medicine. 2021-01-13
Press Mentions
FDA Removes CAR-T Access Barrier in Move Set to Boost Cancer Immunotherapy UptakeJune 27th, 2025
CAR-T Warning for Secondary Malignancies: Warranted or Not?January 5th, 2025
FDA Approves Symvess, an Acellular Tissue-Engineered VesselJanuary 3rd, 2025
